BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29679984)

  • 1. Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report.
    Tummolo A; Melpignano L; Carella A; Di Mauro AM; Piccinno E; Vendemiale M; Ortolani F; Fedele S; Masciopinto M; Papadia F
    J Med Case Rep; 2018 Apr; 12(1):103. PubMed ID: 29679984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia.
    Jones S; Reed CA; Vijay S; Walter JH; Morris AA
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S219-22. PubMed ID: 18338235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria.
    Filippi L; Gozzini E; Fiorini P; Malvagia S; la Marca G; Donati MA
    Neonatology; 2010; 97(3):286-90. PubMed ID: 19887858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia.
    Kasapkara CS; Ezgu FS; Okur I; Tumer L; Biberoglu G; Hasanoglu A
    Eur J Pediatr; 2011 Jun; 170(6):799-801. PubMed ID: 21207059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
    Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
    Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia.
    Gebhardt B; Dittrich S; Parbel S; Vlaho S; Matsika O; Bohles H
    J Inherit Metab Dis; 2005; 28(2):241-4. PubMed ID: 15877213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia.
    Ah Mew N; McCarter R; Daikhin Y; Nissim I; Yudkoff M; Tuchman M
    Pediatrics; 2010 Jul; 126(1):e208-14. PubMed ID: 20566609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia.
    Schwahn BC; Pieterse L; Bisset WM; Galloway PG; Robinson PH
    Eur J Pediatr; 2010 Jan; 169(1):133-4. PubMed ID: 19680687
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term N-carbamylglutamate treatment of hyperammonemia in patients with classic organic acidemias.
    Kiykim E; Oguz O; Duman C; Zubarioglu T; Cansever MS; Zeybek ACA
    Mol Genet Metab Rep; 2021 Mar; 26():100715. PubMed ID: 33552909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
    Valayannopoulos V; Baruteau J; Delgado MB; Cano A; Couce ML; Del Toro M; Donati MA; Garcia-Cazorla A; Gil-Ortega D; Gomez-de Quero P; Guffon N; Hofstede FC; Kalkan-Ucar S; Coker M; Lama-More R; Martinez-Pardo Casanova M; Molina A; Pichard S; Papadia F; Rosello P; Plisson C; Le Mouhaer J; Chakrapani A
    Orphanet J Rare Dis; 2016 Mar; 11():32. PubMed ID: 27030250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of carglumic acid in the treatment of hyperammonaemia during metabolic decompensation of patients with propionic acidaemia.
    Abacan M; Boneh A
    Mol Genet Metab; 2013 Aug; 109(4):397-401. PubMed ID: 23791308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
    Kenneson A; Singh RH
    Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient treatment of propionic acidemia-associated hyperammonemia with N-carbamoyl-L-glutamate in an infant.
    Soyucen E; Demirci E; Aydin A
    Clin Ther; 2010 Apr; 32(4):710-3. PubMed ID: 20435240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-carbamylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria.
    Gebhardt B; Vlaho S; Fischer D; Sewell A; Böhles H
    Mol Genet Metab; 2003 Aug; 79(4):303-4. PubMed ID: 12948747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic changes associated with hyperammonemia in patients with propionic acidemia.
    Filipowicz HR; Ernst SL; Ashurst CL; Pasquali M; Longo N
    Mol Genet Metab; 2006 Jun; 88(2):123-30. PubMed ID: 16406646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial.
    Alfadhel M; Nashabat M; Saleh M; Elamin M; Alfares A; Al Othaim A; Umair M; Ahmed H; Ababneh F; Al Mutairi F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Almannai M; Aljeraisy M; Albdah B; Hussein MA; Rahbeeni Z; Alasmari A
    Orphanet J Rare Dis; 2021 Oct; 16(1):422. PubMed ID: 34635114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.
    Tuchman M; Caldovic L; Daikhin Y; Horyn O; Nissim I; Nissim I; Korson M; Burton B; Yudkoff M
    Pediatr Res; 2008 Aug; 64(2):213-7. PubMed ID: 18414145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.
    Yap S; Lamireau D; Feillet F; Ruiz Gomez A; Davison J; Tangeraas T; Giordano V
    Drugs R D; 2024 Mar; 24(1):69-80. PubMed ID: 38198106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy.
    Elpeleg O; Shaag A; Ben-Shalom E; Schmid T; Bachmann C
    Ann Neurol; 2002 Dec; 52(6):845-9. PubMed ID: 12447942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.